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Abstract
Background: Malignant mesothelioma is a rare and aggressive tumor with a poor prognosis. Distant metastases are very
rare, and the oral cavity metastases are exceedingly rare. Only a few cases with metastasis to oral gingiva are reported.
To our knowledge, this is the first case report of pleural mesothelioma metastasized to the retromolar trigone.
Case presentation: A 59-year-old male was referred with a painless growth at retromolar trigone area. It had been
present for 2 months and had increased in size during this period of time. Past medical history revealed a malignant
mesothelioma. Intraoral examination showed a soft, haemorrhagic, ulcerated lesion at the right retromolar trigone area.
There was no destruction of the bony architecture. An incisional biopsy was performed under local anaesthesia. Based
on the histopathological and immunohistochemical findings, a final diagnosis of metastatic mesothelioma was made.
The patient was informed about the possibility of multiple metastases within the body, but he succumbed after 45 days
following deterioration of his medical condition.
Conclusions: Biopsy, history of the patient and clinical picture were provided to the clinicians to make an efficient
differential diagnosis. Differential diagnosis must be performed with other oral cancers, because the management is
totally different.
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Background
Malignant mesothelioma is a malignant neoplasm of
mesodermal origin and arises from multipotential meso-
thelial or subserosal cells of the pleura, pericardium and
peritoneum. There are different forms: epithelioid (60 %),
sarcomatoid (10–20 %) and biphasic patterns (20–30 %)
[1]. Distant metastases are very rare, and the oral cavity
metastases are exceedingly rare [2]. An English literature
review revealed seven cases on the tongue, two cases of
the mandibular gingiva, two cases of the buccal mucosa,
one case of the bone associated with the mandibular third
molar and one case of the floor of the mouth [3]. Ohnishi
et al. [4] reported another four cases of oral gingiva metas-
tasis from diffuse malignant pleural mesothelioma. This is
the first case of a metastasis of mesothelioma encountered
in the retromolar trigone. Metastases are more common
in the jaw bones than the soft tissue. The most common
sites for men are the lungs (27 %), kidneys (13 %) and skin
(13 %)—for women, the breast (24 %) and genital organs
(17 %), followed by the bone (10 %) and kidney (10 %) [5].
Hirshberg et al [6] reported 58 cases (50 males, 7 females)
of metastasis to the jaw bone whereas 54 cases (42 males,
7 females) of metastasis to the oral mucosa out of 112
patients having lung cancer. He also reported 36 cases (21
males, 15 females) of metastasis to the jaw bone and 29
cases (19 males, 9 females) of metastasis to the oral
mucosa out of 65 patients having kidney cancer [6].
Patients with breast cancer (3 males, 108 females) met-
astasized in the jaw bone in 91 patients (1 male, 90
females) and to the oral mucosa in 20 patients (2 males,
18 females) [6]. The reason for this gender-dependent
metastatic pattern has not completely been elucidated yet.
In 90 % of all pleural mesothelioma, asbestos association
due to occupational exposure is reported. Most people are
in their fourth to seventh decade at the time of diagnosis
[5]. The latency between exposure and manifestation takes
approximately 20–40 years. Occurrence of the malignant
disease typically carries an average survival rate of 9–
12 months. In the present case report, a patient with a
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history of malignant pleural mesothelioma with metastatic
disease to the retromolar trigone is presented.
Case presentation
A 59-year-old male was referred to the Department of
Oral and Maxillofacial Surgery with a painless growth at
retromolar trigone area. It had been present for 2 months
and had increased in size during this period of time. Past
medical history revealed a malignant mesothelioma
which was diagnosed in September 2011 and treated
with chemotherapy and radiotherapy until February
2014. The patient received 6 cycles of cisplatin (50 mg/
100 ml, every 28 days) and premetrexed (500 mg, every
3 weeks) at the beginning. Since the lesion was inoper-
able, radiotherapy (50 Gy, in 25 fractions) was given
after chemotherapy sessions. After radiotherapy sessions,
starting from April 2012, the patient received 5 cycles of
premetrexed (500 mg, every 3 weeks). A different re-
gimen was given starting from January 2013. Cisplatin
(50 mg/100 ml, every 28 days) and gemcitabine
(1000 mg/m2) were prescribed. Gemcitabine was given
on the 1st, 8th and 15th days. He was 71 kg when gem-
citabine was started. After 4 months, the patient was
66 kg. Pemetrexed (500 mg, every 3 weeks) was pre-
scribed instead of gemcitabine. The patient received
750 mg pemetrexed every 3 weeks until December 2013.
In August 2013, positron emission tomography (PET
CT) of the patient was evaluated. Figures 1 and 2 show
the location of the tumor on the left lung and also pos-
sible metastasis on C7 vertebrae. He was 63 kg on that
Fig. 1 Coronal PET (positron emission tomography) image showed higher FDG (fluorodeoxyglucose) uptake in the left lung and the lymph
nodes on the left side
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date. In January 2014, the patient was referred to our
department because of the complaint in the oral region.
Intraoral examination revealed a soft, haemorrhagic,
ulcerated lesion at the right retromolar trigone area
(Fig. 3). Extraorally neither swelling nor lympadenopathy
was observed. The innervation of N. trigeminus was
balanced on both sides. There was no paresthesia on the
lingual nerve. Radiologic examination revealed no
destruction of the bony architecture (Fig. 4). An inci-
sional biopsy was performed under local anaesthesia.
Haematoxylin and eosin staining showed invasive malig-
nancy at subepithelial area (Fig. 5). Syncytial aggrega-
tions composed of huge cells with pleomorphic nucleus,
distinctive nucleolus and narrow cytoplasms were also
detected (Fig. 6). For immunohistochemical staining, the
slides were stained with antibodies to calretinin (Ready
to use, NeoMarkers, USA), secondary antibodies and
DAB chromogen using standard procedures. Cyto-
plasmic/nuclear calretinin expression was considered
positive. Intensity of staining was graded 3. The tumor
cells were strongly positive for calretinin on immunoh-
istochemical staining (Fig. 7). Based on these histop-
athological and immunohistochemical findings, a final
diagnosis of metastatic mesothelioma was made. The pa-
tient was informed about the possibility of multiple me-
tastases within the body. He succumbed after 45 days
following the deterioration of his medical condition.
Discussion
Malignant mesothelioma is a rare and aggressive tumor
with a poor prognosis. The incidence of this disease is
one or two cases per million per year [7]. The diagnosis
of the primary malignant mesothelioma is established by
clinical, histological, immunohistochemical, and radiological
findings. In the present report, calretinin, a mesothelial
marker turned out to be strongly positive in tumour cells on
immunohistochemical staining, substantiating diagnosis of
an epithelioid mesothelioma metastasis. Calretinin, a helix–
loop–helix structural domain found in calcium-binding
proteins and widely expressed in neural tissue, is expressed
in most cases of epithelioid mesothelioma [8]. For radio-
logical investigations, ESMO (European Society For Medical
Oncology) recommends using CT scanning of the thorax
for the localization of tumor sites and distant metastases or
detecting early response to treatment. They recommend also
MRI in special situations where tumor delineation is neces-
sary [9]. But the diagnosis of the secondary malignant meso-
thelioma in the oral cavity, as in the present case, is based
on the presence of known history of the tumor. Even with
the presence of the primary tumor, it is necessary to make a
definite diagnosis of an assumed oral metastases to allow for
an appropriate management. Although the clinical behav-
iour and the view of the primary oral squamous cell carcin-
oma (OSCC) is unlikely to be misdiagnosed for a metastatic
lesion by an experienced surgeon, OSCC is the most likely
diagnosis of a persistent mass, without obvious traumatic or
infectious origin. Wide surgical excision is often an accept-
able treatment for the management of OSCC, whereas in a
metastatic mesothelioma case, it will be inappropriate [10].
The current effective standard treatment for mesothelioma
is the addition of bevacizumab to pemetrexed plus cisplatin
which significantly improves the overall survival [11]. Unfor-
tunately, there was no effective standard treatment for
mesothelioma during the follow-up period of the present
patient. Therefore, another different regimen of chemother-
apy was prescribed. Although the cisplatin plus pemetrexed
Fig. 2 a Chest CT presenting mesothelioma. b, c Axial PET images with higher tracer uptake. d Axial PET image indicating C7 vertebrae having a
possible metastatic view
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Fig. 4 Panoramic radiograph of the patient
Fig. 3 Intraoral view of the patient
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therapy of the present patient was the standard of care in
the first-line treatment, the prognosis was poor and the
patient succumbed to the disease.
Malignant mesotheliomas frequently recurred locally in
the chest and abdomen. Metastases occur at a relatively late
stage of the disease. Kannerstein and Churg [12] reported
metastases in 18/50 autopsy cases. Distant metastases are
very rare, especially in the oral region. Primary breast car-
cinomas are the most common types of tumour to
metastasize to the jaw bones while primary lung carcin-
omas are the most common types of tumour to metastasize
to the oral soft tissue [13]. These oral metastases represent
about 1 % of oral malignances, and there are more cases re-
ported arising in the jaw bones than in the oral soft tissues
with a ratio of approximately 2:1 [14]. The case presented
in this report is only the first report of a mesothelioma
metastatic to the retromolar trigone. Although Kruse et al.
[13] and Hirshberg et al. [6] reported that metastases of
mesothelioma, although rare, tend to involve the oral soft
tissues, especially the tongue. Sinon et al.[3] reported that
metastases to oral region are mostly seen in the tongue and
the attached gingiva. One possible explanation for the ten-
dency towards the tongue and the attached gingiva might
be the rich capillary network, especially where chronically
Fig. 5 Invasive malignancy at subepithelial area (HE ×40)
Fig. 6 Huge cells with pleomorphic nucleus and narrow cytoplasms
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inflamed gingiva trap malignant cells and the fragmented
basement membranes of proliferation capillaries allow
easier penetration by malignant cells than in more mature
blood cells [15].
Conclusions
This case report points out the relevance of biopsy to all
new growing lesions, even in uncommon anatomical
sites, whenever a history of mesothelioma is on record.
Biopsy, history of the patient and clinical picture were
provided to the clinicians to make an efficient differen-
tial diagnosis. An accurate diagnosis is very important to
avoid inappropriate futile surgery and help maintain the
patients’ quality of life with the aim of improving the
oral condition.
Abbreviations
FDG, fluorodeoxyglucose; N. trigeminus, nervus trigeminus; OSCC,
oral squamous cell carcinoma; PET, positron emission tomography
Acknowledgements
The authors declare that there is no acknowledgements.
Funding
The authors declare no funding for the present case report.
Availability of data and materials
The datasets generated during and/or analysed during the current
study are available in Istanbul University, Faculty of Medicine, Department
of Oncology, Istanbul, and Patomed Pathology Laboratory, Istanbul
(Number: S141-9531C). Other records related to oral procedures of the
patient are available in Yeditepe University, Faculty of Dentistry, Istanbul
(Protocol Number: 96303). The datasets during and/or analysed during the current
study are also available from the corresponding author on reasonable request.
Authors’ contributions
AA wrote the manuscript. COT and ED acquired the data. OA performed the
histopathologic examination. AA and COT interpreted the data and drafted
the manuscript. All authors read and approved the final manuscript.
Author’s information
AA, COT and ED are associate professors in Yeditepe University, Faculty of
Dentistry, Department of Oral and Maxillofacial Surgery. They are all
interested in oral diseases and oral surgical procedures. They are all in the
academic staff of the faculty (Education for the dentistry students), and they
give lectures about their topics. They also perform oral surgery in the
university. OA is a private pathologist, working in a private pathology
laboratory. His residency was in Eastern Virginia Medical School,
Virginia—Combined Anatomic and Clinical Pathology and Sinai Hospital of
Baltimore, Maryland, and was a clinical trainee in Surgery at Johns Hopkins
University. He had a fellowship in Cornell University, North Shore University
Hospital, Surgical Pathology and Cytopathology, New York, between July
1995 and June 1996. He has got his Turkish Pathology Specialty degree in
1997 and his board degree from The American Board of
Pathology—Anatomic and Clinical—in May 1996.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Written informed consent was obtained from the patient for publication
of this case report and accompanying images.
Ethics approval and consent to participate
Ethical approval is obtained from the Ethical Committee of Clinical Investigations
of Yeditepe University (Application Number: 37068608-6100-15-1194/Decision
Number: 593). Consent of the patient was obtained to participate to the
presentation of this report.
Author details
1Faculty of Dentistry, Department of Oral and Maxillofacial Surgery, Yeditepe
University, Bagdat Cad, No: 238, Goztepe, 34728 Istanbul, Turkey. 2Patomed
Pathology Laboratory, Gursel Mah, Darulaceze Cad, Eksioglu Is Merkezi, Kat:3,
No: 36, D:4, Okmeydani, Istanbul, Turkey.
Received: 1 March 2016 Accepted: 8 July 2016
References
1. Zandwijk NV, Clarke C, Henderson D, Musk AW, Fong K, et al. Guidelines for
the diagnosis and treatment of malignant pleural mesothelioma. J Thorac
Dis. 2013;5(6):E254–307.
Fig. 7 Strong positivity for calretinin on immunohistochemical staining
Arslan et al. World Journal of Surgical Oncology  (2016) 14:188 Page 6 of 7
2. Billè A, Platania M, Pelosi G, Padovano B, Quattrone P, Pastorino U. Gingival
metastasis as first sign of multiorgan dissemination of epithelioid malignant
mesothelioma. J Thorac Oncol. 2014;9:1226–9.
3. Sinon SH, Rich AM, Hussaini HM, Yoon HS, Firth NA, Seymour GJ. Metastases
to the oral region from pleural mesothelioma: clinicopathologic review.
Head Neck. 2013;35:599–604.
4. Ohnishi Y, Sugitatsu M, Watanabe M, Fujii T, Kakudo K. Metastasis of
mesothelioma to the maxillary gingiva. Oncol Lett. 2014;8:1214–6.
5. Hirshberg A, Leibovich P, Buchner A. Metastases to the oral mucosa: analysis
of 157 cases. J Oral Pathol Med. 1993;22:385–90.
6. Hirshberg A, Shnaiderman-Shapiro A, Kaplan I, Berger R. Metastatic tumors to oral
cavity—pathogenesis and analysis of 673 cases. Oral Oncol. 2008;44:743–52.
7. Suzuki Y. Diagnostic criteria for human diffuse malignant mesothelioma.
Acta Pathol Jpn. 1992;42:767–86.
8. Doglioni C, Dei Tos AP, Laurino L, et al. Calretenin: a novel immunocytochemical
marker for mesothelioma. Am J Surg Pathol. 1996;20:1037–46.
9. Baas P, Fennell D, Kerr KM, et al. Malignant pleural mesothelioma: ESMO
clinical practice guidelines for diagnosis, treatment and follow-up. Ann
Oncol. 2015;26 Suppl 5:v31–9.
10. Kirke D, Horwood K, Wallwork B. Floor of mouth and tongue metastasis
from malignant pleural mesothelioma. ANZ J Surg. 2010;80:556–8.
11. Zalcman G, Mazieres J, Margery J, Greillier L, Audigier-Valette C, et al.
Bevacizumab for newly diagnosed pleural mesothelioma in the
Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised,
controlled, open-label, phase 3 trial. Lancet. 2016;387(10026):1405–14.
12. Kannerstein M, Churg J. Peritoneal mesothelioma. Hum Pathol. 1977;8:83–94.
13. Kruse A, Luebbers HT, Obwegeser J, Edelmann L, Grätz KW.
Temporomandibular disorders associated with metastases to the
temporomandibular joint: a review of the literature and 3 additional cases.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110:e21–8.
14. Terakado N, Shintani S, Nakashiro K, Hamakawa H. Malignant pleural
mesothelioma metastasis to the mandible. Int J Oral Maxillofac Surg.
2004;33:798–800.
15. Nagy JA, Brown LF, Senger DR, Lanir N, Van de Water L, Dvorak AM, Dvorak
HF. Pathogenesis of tumor stroma generation: a critical role for leaky blood
vessels and fibrin deposition. Biochem Biophys Acta. 1989;948:305–6.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Arslan et al. World Journal of Surgical Oncology  (2016) 14:188 Page 7 of 7
